文献速递神经与头颈病理细胞病理与分子病理

甲状腺筛状-桑葚样癌:WNT/β-catenin通路激活的特殊表型肿瘤

Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway.
PubMed 文献 · Mod Pathol · 2018-05-21

甲状腺筛状-桑葚样癌与家族性腺瘤性息肉病相关,也可散发,女性远多于男性(61:1)。家族性病例多灶/双侧,散发多为单结节。肿瘤呈筛状、桑葚样等多种结构混合,β-catenin核/质染色为标志,属非BRAF非RAS分子亚型,预后好但神经内分泌或低分化提示侵袭性。

要点

  • 诊断该变异型时应警惕家族性腺瘤性息肉病可能。
  • β-catenin核/质染色是标志,可用于细针穿刺活检辅助诊断。
  • 肿瘤通常预后好,但神经内分泌或低分化与侵袭行为相关。

核心结论

  • 甲状腺筛状-桑葚样癌具有独特的内胚层(肠样)表型及WNT/β-catenin通路激活,宜称为筛状-桑葚样甲状腺癌而非乳头状癌变异型。

研究设计与样本

  • 原文为综述性描述,未报告系统检索范围及样本量。

主要发现

  • 女性与男性比例约为61:1。
  • 家族性腺瘤性息肉病患者肿瘤多灶和/或双侧(多结节外观),散发病例多为单结节。
  • 血管侵犯和包膜侵犯分别约占30%和40%,淋巴结转移见于不足10%的患者,远处转移占6%。
  • 肿瘤细胞甲状腺球蛋白可局灶阳性或阴性,但TTF-1、雌激素和孕激素受体 always 阳性,降钙素和细胞角蛋白20阴性。
  • β-catenin核和胞质染色是本肿瘤标志,在细针穿刺活检中有作用。

关键数值与推荐

  • 桑葚体细胞核透亮,CDX2和CD10阳性。
  • 肿瘤属甲状腺分子分类中的非BRAF非RAS亚型。
  • 雌激素和孕激素受体高表达及WNT/β-catenin通路激活可能作为常规治疗无效病例的潜在治疗靶点。

临床怎么用

  • 诊断筛状-桑葚样甲状腺癌时,应提醒临床医生排查家族性腺瘤性息肉病。
  • 利用β-catenin核/质染色辅助细针穿刺活检诊断。
  • 对常规治疗无效病例,可考虑雌激素/孕激素受体及WNT/β-catenin通路作为潜在治疗靶点。

局限性

  • 原文未报告系统检索范围、样本量及具体研究设计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cribriform-morular variant of thyroid carcinoma is classically associated with familial adenomatous polyposis but, it can also occur as a sporadic neoplasm. This neoplasm is much more frequently observed in women than in men (ratio of 61:1). In familial adenomatous polyposis patients, tumors are generally multifocal and/or bilateral (multinodular appearance), whereas in the sporadic cases tumors tend to occur as single nodules. The tumors are well delimited, and characteristically show a blending of follicular, cribriform, papillary, trabecular, solid, and morular patterns. Neoplastic cells are tall or cuboidal with the occasional nuclear features of classic papillary thyroid carcinoma. The morules include cells with peculiar nuclear clearing and show positivity for CDX2 and CD10. Angioinvasion and capsular invasion have been described in about 30 and 40% of cases, respectively, with lymph node metastases in less than 10% of patients and distant metastases in 6%. Although this tumor has good prognosis, neuroendocrine and/or poor differentiation have been associated with aggressive behavior. Tumor cells can be focally positive or negative for thyroglobulin, but are always positive for TTF-1, estrogen and progesterone receptors, and negative for calcitonin and cytokeratin 20. Nuclear and cytoplasmic staining for β-catenin is the hallmark of this tumor type; this feature plays a role in fine needle aspiration biopsy. Cribriform-morular variant of thyroid carcinoma has a peculiar endodermal (intestinal-like) type phenotype, activation of the WNT/β-catenin signaling pathway, and belongs to the non-BRAF-non-RAS subtype of the molecular classification of thyroid tumors. Elevated expression of estrogen and progesterone receptors and activation of the WNT/β-catenin pathway may prove useful as putative therapeutic targets in cases that do not respond to conventional therapy. Clinicians should be alerted to the possibility of familial adenomatous polyposis when a diagnosis of cribriform-morular variant of thyroid carcinoma is made. Instead of being considered as a variant of papillary thyroid carcinoma its designation as cribriform-morular thyroid carcinoma seems more appropriate.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Cameselle-Teijeiro JM, Peteiro-González D, Caneiro-Gómez J, et al. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway. Mod Pathol. 2018. PMID: 29785019. doi:10.1038/s41379-018-0070-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。